Was there any disclosure that life-threatening litigation was under way? Surely the directors would have known the risk but I don't remember seeing it in the rights prospectus for example.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
